Erythropoietin and G-CSF receptors in human tumor cells: Expression and aspects regarding functionality

Tumori

Volumn 88, Issue 2, 2002, Pages 150-159

  Westphal, Gabriela ^a   Niederberger, Ellen ^a   Blum, Christoph ^a   Wollman, Yoram ^a   Knoch, Tobias A ^a   Rebel, Wolfgang ^a   Debus, Jürgen ^a   Friedrich, Eckhard ^a  

^a NONE   (Germany)

Author keywords

Epo; G CSF; Human Epo receptor (EpoR); Human G CSF receptor; Human tumor cell lines

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; PROTEIN C FOS; PROTEIN TYROSINE KINASE; THYMIDINE; TRITIUM;

ARTICLE; CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG RECEPTOR BINDING; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NORTHERN BLOTTING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0036269105     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800214     Document Type: Article

References (54)

1. Erythropoietin
2. Erythropoietin in the control of red cell production
3. Effekte von rekombinantem humanem erythropoietin auf den transfusionsbedarf und die hämoglobinkonzentration bei patienten mit soliden tumoren und chemotherapie-induzierter anämie
4. Erythropoietin and erythropoietin receptor
5. Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox state of the brain
6. The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner
7. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain
8. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates
9. Expression of specific high-affinity sites for erythropoietin on rat and mouse megakaryocytes
10. Erythropoietin receptor mRNA expression in human endothelial cells
11. Evidence for specific binding and stimulatory effects of recombinant human erythropoietin on isolated rat Leydig cells
12. The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: Evidence for differentiation stage-specific regulation
13. Erythropoietin as a mitogen for fetal liver stromal cells with support erythropoiesis
14. Receptors for erythropoietin in mouse and human erythroid cells and placenta
15. Cloning of the human erythropoietin receptor gene
16. Establishment and characterization of an erythropoietin-dependent subline UT-7/Epo, derived from human leukemia cell line UT-7
17. Erythropoietin stimulates proliferation of human renal carcinoma cells
18. Erythropoietin receptor expression in human melanoma cells
19. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells
20. Erythropoietin gene expression in human, monkey and murine brain
21. The erythropoietin receptor: Structure, activation, and intracellular signal transduction
22. Granulocyte colony-stimulating factor
23. Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cells
24. G-CSF receptor expression in ovarian cancer
25. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction
26. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor
27. The regulated expression of erythropoietin by two human hepatoma cell lines
28. Serum erythropoietin levels in patients with solid tumours
29. Erythropoietin and anemia of cancer
30. Studies on the role of recombinant erythropoietin in the growth regulation of human nonhematopoietic cells in vitro
31. Effect of recombinant human erythropoietin on the hematopoietic and non-hematopoietic malignant cell growth in vitro
32. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes
33. Anti-erythropoietin receptor (EPO-R) monoclonal antibodies inhibit erythropoietin binding and neutralize bioactivity
34. Expression and modulation of specific high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562
35. Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL
36. Human hematopoietic progenitors express erythropoietin
37. Experimental data concerning the safety profile of Epo in the treatment of cancer patients
38. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1
39. Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor
40. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines
41. Truncated erythropoietin receptor in a murine erythroleukemia cell line
42. "Benign erythrocytosis" and other familial and congenital poly-cythemias
43. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia
44. Alteration of nuclear proto-oncogene expression by erythropoietin in Epo-responsive murine cell lines
45. Human granulocyte colony-stimulating factor: Biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines
46. G-CSF production in human bladder cancer and its ability to promote autocrine growth: A review
47. Anemia of cancer patients: Patient selection and patient stratification for epoetin treatment
48. Anemia of cancer: Pathogenesis and treatment with recombinant erythropoietin
49. Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors
50. Anemia in children with cancer is associated with decrased erythropoietic activity and not with inadequate erythropoietin production
51. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: Evidence for in vivo synergy
52. Treatment of anemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin
53. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: A randomized trial
54. The effect of human recombinant erythropoietin on the growth of a human neuroblastoma cell line